Isolation of Aspergillus spp. in respiratory samples of patients with COVID‐19 in a Spanish Tertiary Care Hospital
Open Access
- 4 August 2020
- Vol. 63 (11), 1144-1148
- https://doi.org/10.1111/myc.13155
Abstract
Background Invasive pulmonary aspergillosis (IPA) is a complication of respiratory bacterial and viral infections such as coronavirus disease 2019 (COVID‐19). Patients/Methods In University Hospital La Paz (Madrid, Spain), we reviewed the clinical and demographic characteristics of 10 patients with positive severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) PCR and Aspergillus spp. isolate in respiratory samples. We also recovered results of galactomannan tests in serum and/or bronchoalveolar lavage (BAL) samples. Results Eight male and two female from 51 to 76 years were recovered. They had reported risk factors to develop IPA (hematological malignancies, immunosuppression, diabetes, obesity, intensive care unit stay, among others). Azole susceptible Aspergillus fumigatus was isolated in nine patients and Aspergillus nidulans was isolated in one patient. Only one case was classified as probable aspergillosis, seven cases as putative aspergillosis, and two cases were not classifiable. Eight patients received antifungal treatment. Seven patients died (70%), two are still inpatient due to nosocomial infections and one was discharged referred to another institution. Conclusions This clinical entity has high mortality and therefore it should be performed surveillance with early galactomannan tests and cultures in respiratory samples in order to improve the outcome of the patients with this condition.Keywords
This publication has 10 references indexed in Scilit:
- COVID-19–associated Pulmonary AspergillosisAmerican Journal of Respiratory and Critical Care Medicine, 2020
- Fatal Invasive Aspergillosis and Coronavirus Disease in an Immunocompetent PatientEmerging Infectious Diseases, 2020
- Clinical characteristics of invasive pulmonary aspergillosis in patients with COVID-19 in Zhejiang, China: a retrospective case seriesCritical Care, 2020
- Invasive pulmonary aspergillosis complicating COVID-19 in the ICU - A case reportMedical Mycology Case Reports, 2020
- COVID‐19 associated pulmonary aspergillosisMycoses, 2020
- Bacterial and fungal infections in COVID-19 patients: A matter of concernInfection Control & Hospital Epidemiology, 2020
- Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research ConsortiumClinical Infectious Diseases, 2019
- Invasive pulmonary aspergillosis complicating severe influenza: epidemiology, diagnosis and treatmentCurrent Opinion in Infectious Diseases, 2018
- Multicenter Study of Isavuconazole MIC Distributions and Epidemiological Cutoff Values for Aspergillus spp. for the CLSI M38-A2 Broth Microdilution MethodAntimicrobial Agents and Chemotherapy, 2013
- A Clinical Algorithm to Diagnose Invasive Pulmonary Aspergillosis in Critically Ill PatientsAmerican Journal of Respiratory and Critical Care Medicine, 2012